The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...

If you fight fall allergies with this possible swap for Zyrtec, Claritin, or Allegra, the FDA warns it's been recalled due to ...

The Global Hyperhidrosis Treatment Market Size is projected to grow at a CAGR of 5.89% from 2026 to 2032, according to a new report ...

Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock ...

The Supreme Court on Monday agreed to take up whether a federal crime that bans gun possession for drug users is ...

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of ...

The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors ...

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of ...

Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) just unveiled an announcement. Shanghai Henlius Biotech, Inc. announced that its subsidiary, ...

Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.

Tramadol Hydrochloride, marketed as Treken-100, is a prohibited psychotropic substance under the NDPS Act and is commonly ...